The Oncosearch | Oncotarget

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer Research Paper

Yoshimasa Miyagawa, Ayako Yanai, Takehiro Yanagawa, Junichi Inatome, Chiyomi Egawa, Arisa Nishimukai, Kaori Takamoto, Takashi Morimoto, Yuichiro Kikawa, Hirofumi Suwa, Tomoe Taji, Ai Yamaguchi, Yuki Okada, Atsushi Sata, Reiko Fukui, Ayako Bun, Hiromi Ozawa, Tomoko Higuchi, Yukie Fujimoto, Michiko Imamura, Yasuo Miyoshi

Published Dec 31, 2019

Keywords: Breast cancer, bevacizumab, neutrophil-to-lymphocyte ratio, c-reactive protein, predictive marker

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer Research Paper

Yoshimasa Miyagawa, Ayako Yanai, Takehiro Yanagawa, Junichi Inatome, Chiyomi Egawa, Arisa Nishimukai, Kaori Takamoto, Takashi Morimoto, Yuichiro Kikawa, Hirofumi Suwa, Tomoe Taji, Ai Yamaguchi, Yuki Okada, Atsushi Sata, Reiko Fukui, Ayako Bun, Hiromi Ozawa, Tomoko Higuchi, Yukie Fujimoto, Michiko Imamura, Yasuo Miyoshi

Published Dec 31, 2019

Keywords: Breast cancer, bevacizumab, neutrophil-to-lymphocyte ratio, c-reactive protein, predictive marker

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer Research Paper

Yoshimasa Miyagawa, Ayako Yanai, Takehiro Yanagawa, Junichi Inatome, Chiyomi Egawa, Arisa Nishimukai, Kaori Takamoto, Takashi Morimoto, Yuichiro Kikawa, Hirofumi Suwa, Tomoe Taji, Ai Yamaguchi, Yuki Okada, Atsushi Sata, Reiko Fukui, Ayako Bun, Hiromi Ozawa, Tomoko Higuchi, Yukie Fujimoto, Michiko Imamura, Yasuo Miyoshi

Published Dec 31, 2019

Keywords: Breast cancer, bevacizumab, neutrophil-to-lymphocyte ratio, c-reactive protein, predictive marker

Dysregulation of adenosine kinase isoforms in breast cancer Research Paper

Bahar Shamloo, Nandita Kumar, Randall H. Owen, Jesica Reemmer, John Ost, R. Serene Perkins, Hai-Ying Shen

Published Dec 31, 2019 · Vol. 10, No. 68 · pp. 7238-7250

Keywords: adenosine kinase, breast cancer, adenosine kinase isoforms, metastasis, proliferation

Targeting the non-canonical roles of PCNA modifies and increases the response to targeted anti-cancer therapy Research Paper

Caroline K. Søgaard, Anala Nepal, Voin Petrovic, Animesh Sharma, Nina-Beate Liabakk, Tonje S. Steigedal, Marit Otterlei

Published Dec 31, 2019 · Vol. 10, No. 68 · pp. 7185-7197

Keywords: APIM, multi-targeting therapy, signaling pathways, autophagy, cancer

Prognostic role of microRNAs in breast cancer: A systematic review Review

Eleni Zografos, Flora Zagouri, Despoina Kalapanida, Roubini Zakopoulou, Anastasios Kyriazoglou, Kleoniki Apostolidou, Maria Gazouli, Meletios-Athanasios Dimopoulos

Published Dec 24, 2019 · Vol. 10, No. 67 · pp. 7156-7178

Keywords: breast cancer, microRNAs, prognosis, biomarkers

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Research Paper

Wayne D. Blosser, Jack A. Dempsey, Ann M. Mc Nulty, Xi Rao, Philip J. Ebert, Caitlin D. Lowery, Philip W. Iversen, Yue Wang Webster, Gregory P. Donoho, Xueqian Gong, Farhana F. Merzoug, Sean Buchanan, Karsten Boehnke, Chunping Yu, Xin Tian You, Richard P. Beckmann, Wenjuan Wu, Samuel C. McNeely, Aimee Bence Lin, Ricardo Martinez

Published Dec 16, 2019

Keywords: CHK1, prexasertib, replication stress, replication fork, innate immunity

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Research Paper

Wayne D. Blosser, Jack A. Dempsey, Ann M. Mc Nulty, Xi Rao, Philip J. Ebert, Caitlin D. Lowery, Philip W. Iversen, Yue Wang Webster, Gregory P. Donoho, Xueqian Gong, Farhana F. Merzoug, Sean Buchanan, Karsten Boehnke, Chunping Yu, Xin Tian You, Richard P. Beckmann, Wenjuan Wu, Samuel C. McNeely, Aimee Bence Lin, Ricardo Martinez

Published Dec 16, 2019

Keywords: CHK1, prexasertib, replication stress, replication fork, innate immunity

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Research Paper

Wayne D. Blosser, Jack A. Dempsey, Ann M. Mc Nulty, Xi Rao, Philip J. Ebert, Caitlin D. Lowery, Philip W. Iversen, Yue Wang Webster, Gregory P. Donoho, Xueqian Gong, Farhana F. Merzoug, Sean Buchanan, Karsten Boehnke, Chunping Yu, Xin Tian You, Richard P. Beckmann, Wenjuan Wu, Samuel C. McNeely, Aimee Bence Lin, Ricardo Martinez

Published Dec 16, 2019

Keywords: CHK1, prexasertib, replication stress, replication fork, innate immunity

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Research Paper

Wayne D. Blosser, Jack A. Dempsey, Ann M. Mc Nulty, Xi Rao, Philip J. Ebert, Caitlin D. Lowery, Philip W. Iversen, Yue Wang Webster, Gregory P. Donoho, Xueqian Gong, Farhana F. Merzoug, Sean Buchanan, Karsten Boehnke, Chunping Yu, Xin Tian You, Richard P. Beckmann, Wenjuan Wu, Samuel C. McNeely, Aimee Bence Lin, Ricardo Martinez

Published Dec 16, 2019

Keywords: CHK1, prexasertib, replication stress, replication fork, innate immunity

Modulation of proliferation factors in lung adenocarcinoma with an analysis of the transcriptional consequences of genomic EGFR activation Research Paper

Melanie Haas Kucherlapati

Published Dec 10, 2019 · Vol. 10, No. 65 · pp. 6913-6933

Keywords: proliferation, mutation, transcription, EGFR, lung adenocarcinoma

The phytohormone forchlorfenuron decreases viability and proliferation of malignant mesothelioma cells in vitro and in vivo Research Paper

Walter Blum, Thomas Henzi, László Pecze, Kim-Long Diep, Christian G. Bochet, Beat Schwaller

Published Dec 10, 2019 · Vol. 10, No. 65 · pp. 6944-6956

Keywords: malignant mesothelioma, septin cytoskeleton, septin 7, forchlorfenuron, FCF

Expression of matrix metalloproteinase 2 and 9 in breast cancer and breast fibroadenoma: a randomized, double-blind study Research Paper

Luana Mota Martins, Carla Solange de Melo Escorcio Dourado, Larysse Maira Campos-Verdes, Fabiane Araújo Sampaio, Camila Maria Simplício Revoredo, Danylo Rafhael Costa-Silva, Maria da Conceição Barros-Oliveira, Elmo de Jesus Nery Junior, Lucia Maria do Rego-Medeiros, Luiz Henrique Gebrim, Francisco Adelton Alves-Ribeiro, Gilmara Péres Rodrigues, Diego Cipriano Chagas, Dilina do Nascimento Marreiro, Benedito Borges da Silva

Published Dec 3, 2019 · Vol. 10, No. 64 · pp. 6879-6884

Keywords: breast neoplasms, fibroadenoma, matrix metalloproteinase-2, matrix metalloproteinase-9, immunohistochemistry

Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a Research Paper

Sweta Sikder, Sujata Kumari, Manoj Kumar, Shrinka Sen, Namrata Bora Singhal, Srikumar Chellappan, Mukul Godbole, Pratik Chandrani, Amit Dutt, Kodaganur S. Gopinath, Tapas K. Kundu

Published Dec 3, 2019 · Vol. 10, No. 64 · pp. 6855-6869

Keywords: tumour suppressor, non-histone chromatin protein, oncomiR, matrix metalloproteinases, p53 activation

A way forward for cancer prevention therapy: personalized risk assessment Review

Zhenzhen Zhang, Jeffrey Bien, Motomi Mori, Sonali Jindal, Raymond Bergan

Published Dec 3, 2019 · Vol. 10, No. 64 · pp. 6898-6912

Keywords: cancer, prevention, prevention therapy, multiple risk factors, screening

Survival correlation of immune response in human cancers Research Paper

Yuexin Liu

Published Dec 3, 2019 · Vol. 10, No. 64 · pp. 6885-6897

Keywords: overall survival, progression-free interval, immune response, immunogenicity, cancer

The impact of systemic precision medicine and immunotherapy treatments on brain metastases Review

Rowland H. Han, Gavin P. Dunn, Milan G. Chheda, Albert H. Kim

Published Nov 19, 2019 · Vol. 10, No. 62 · pp. 6739-6753

Keywords: brain metastases, targeted therapy, precision medicine, immunotherapy, systemic therapy

Correction: FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells Correction

Ming Zhao, Ming-Lei Zhuo, Xiaofeng Zheng, Xiaoping Su, Funda Meric-Bernstam

Published Nov 16, 2019 · Vol. 10, No. 65 · pp. 7014-7015

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target Research Paper

Guilhem Bousquet, Jean-Paul Feugeas, Yuchen Gu, Christophe Leboeuf, Morad El Bouchtaoui, He Lu, Marc Espié, Anne Janin, Melanie Di Benedetto

Published Nov 12, 2019 · Vol. 10, No. 61 · pp. 6577-6588

Keywords: triple-negative breast cancer, chemotherapy resistance, apoptosis-inhibitor-5, peptide, anti-angiogenic therapy

The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44 Research Paper

Chunmei Zhao, Benjamin J. Thompson, Kelly Chen, Feng Gao, Barbara Blouw, Mathieu Marella, Susan Zimmerman, Trevor Kimbler, Sheryl Garrovillo, Jesse Bahn, Lei Huang, Zhongdong Huang, H. Michael Shepard, Sanna Rosengren, Christopher D. Thanos, Daniel C. Maneval

Published Nov 12, 2019 · Vol. 10, No. 61 · pp. 6561-6576

Keywords: hyaluronan, breast cancer, xenograft, tumor microenvironment, CD44

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer Research Paper

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer Research Paper

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer Research Paper

Dysregulation of adenosine kinase isoforms in breast cancer Research Paper

Targeting the non-canonical roles of PCNA modifies and increases the response to targeted anti-cancer therapy Research Paper

Prognostic role of microRNAs in breast cancer: A systematic review Review

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Research Paper

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Research Paper

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Research Paper

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Research Paper

Modulation of proliferation factors in lung adenocarcinoma with an analysis of the transcriptional consequences of genomic EGFR activation Research Paper

The phytohormone forchlorfenuron decreases viability and proliferation of malignant mesothelioma cells in vitro and in vivo Research Paper

Expression of matrix metalloproteinase 2 and 9 in breast cancer and breast fibroadenoma: a randomized, double-blind study Research Paper

Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a Research Paper

A way forward for cancer prevention therapy: personalized risk assessment Review

Survival correlation of immune response in human cancers Research Paper

The impact of systemic precision medicine and immunotherapy treatments on brain metastases Review

Correction: FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells Correction

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target Research Paper

The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44 Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer Research Paper

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer Research Paper

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer Research Paper

Dysregulation of adenosine kinase isoforms in breast cancer Research Paper

Targeting the non-canonical roles of PCNA modifies and increases the response to targeted anti-cancer therapy Research Paper

Prognostic role of microRNAs in breast cancer: A systematic review Review

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Research Paper

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Research Paper

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Research Paper

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib Research Paper

Modulation of proliferation factors in lung adenocarcinoma with an analysis of the transcriptional consequences of genomic EGFR activation Research Paper

The phytohormone forchlorfenuron decreases viability and proliferation of malignant mesothelioma cells in vitro and in vivo Research Paper

Expression of matrix metalloproteinase 2 and 9 in breast cancer and breast fibroadenoma: a randomized, double-blind study Research Paper

Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a Research Paper

A way forward for cancer prevention therapy: personalized risk assessment Review

Survival correlation of immune response in human cancers Research Paper

The impact of systemic precision medicine and immunotherapy treatments on brain metastases Review

Correction: FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells Correction

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target Research Paper

The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44 Research Paper